Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07737730) titled 'A Study to Assess the Safety of Subcutaneous Secukinumab for Treatment in Adult Indian Participants With Axial Spondyloarthritis (axSpA), Ankylosing Spondylitis (AS), and Non-Radiographic Axial Spondyloarthritis (nr-axSpA)' on July 27.
Study Type: Observational
Primary Sponsor: Novartis Pharmaceuticals
Condition:
Axial Spondyloarthritis
Ankylosing Spondylitis
Non-Radiographic Axial Spondyloarthritis
Recruitment Status: Not recruiting
Date of First Enrollment: September 30, 2026
Target Sample Size: 60
To know more, visit https://clinicaltrials.gov/study/NCT07737730
Disclaimer: Curated by HT Syndication....